Alexandra Valenti

Nektar v. Lilly: Lilly Defeats CRE Claim, But Jury Finds It Owes $90M For Breaching The Implied Covenant Of Good Faith And Fair Dealing

The Case For Keeping AI Disputes Out Of Court

ICC Arbitration Rules Effective June 1, 2026: Key Changes And Practical Takeaways For Parties And Counsel

Arbitrating To Protect AI: Considerations For AI Companies When Adopting Arbitration Clauses

Life Sciences Licensing And M&A Update: Catching Up On Recent Decisions Affecting Commercially Reasonable Efforts Definitions And Post-Patent Expiration Royalty Obligations

Goodwin Releases Update To Its Comprehensive Guide To Biosimilars Litigation And Regulation In The U.S.

MetaBirkins Post-Trial Ruling Clarifies Line Between Trademark Infringement And Free Expression And Grants Broad Injunctive Relief

EMA Adopts Positive Opinion For Amgen's Eculizumab Biosimilar Candidate BEKEMV®

Deal Watch: Henlius Licenses Rituximab And Trastuzumab Products To Abbott In Brazil

Purple Book Updates

Pro Bono Prose: Alexandra Valenti (Podcast)